The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 36.80
Bid: 36.60
Ask: 37.30
Change: 0.00 (0.00%)
Spread: 0.70 (1.913%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 36.80
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: Kingfisher Tops FTSE 100 On CEO Change

Wed, 10th Sep 2014 16:04

LONDON (Alliance News) - UK indices ended Wednesday broadly lower after another volatile session, as underlying concerns of an independent Scotland continue.

The FTSE 100 closed flat at 6,830.11, while the FTSE 250 was again the worst performing of the main London indices falling 0.7% to 15,672.66 and the AIM All-Share ended the day 0.2% lower at 775.61.

European stocks have ended the day lower as well with the French CAC 40 falling 0.1% and the DAX closing 0.1% lower.

At the close of trade in London, US trading was mixed, with the DJIA and the S&P 500 both trading flat and the Nasdaq Composite trading up 0.1%.

The FTSE 100 clawed back initial losses during midday trading but slumped from its intraday high in the absence of fresh economic data. This caused investors to again be subdued by the prospect of an independent Scotland.

"UK markets have recovered from their modest panic on Monday morning, but the referendum will remain the only game in town for another week to come, casting a cloud of uncertainty across UK shares," said Brenda Kelly, chief market strategist at IG.

In individual stock news, Kingfisher ended the day atop the blue-chip index after it said the head of its Castorama business in France, Veronique Laury, will take over as group chief executive before the end of the current financial year, tasked with expanding the company's online sales, integrating recent acquisitions and expanding some of its brands into new markets.

In a statement, the company said current CEO Ian Cheshire will step down by the end of the financial year in January. Cheshire told journalists that after seven years as CEO, and 17 years in the Kingfisher business, he has decided that he did not want to remain in place through the next five-year strategic plan the company has started. Kingfisher's shares closed 4.3% higher.

Barratt Developments also closed the day amongst the biggest gainers in the FTSE 100 with its shares gaining 2.8%. The housebuilder said it plans to return around GBP950 million to shareholders over the next three years, as it more than doubled its final dividend following a strong year underpinned by recovery in the UK housing market.

The company, which will drop out of the FTSE 100 on September 22, said it will pay a final dividend of 7.1 pence for the year that ended June 30, compared with 2.5 pence the year before, making a total dividend of 10.3 pence. The company paid a total dividend of 2.5 pence a year earlier. Under a special cash payment programme, Barratt hopes to make a special cash payment alongside its full-year 2015 results of GBP100 million, followed by a special cash payment of GBP125 million alongside its full-year 2016 results and a special cash payment of GBP175 million with its full-year 2017 results.

The capital return plan came as the housebuilder posted pretax of GBP390.6 million for the year to June 30, up from GBP192.0 million a year earlier, as revenue rose 21% to GBP3.16 billion from GBP2.60 billion.

Thursday's economic calendar brings Europe back into focus with German consumer price index data for August being released at 0700 BST while the European Central Bank monthly report will be released at 0900 BST.

In the corporate calendar, FTSE 100-listed Next and Wm Morrison Supermarket and AIM-listed Futura Medical will release half-year results, while FTSE 250 asset manager Ashmore Group will be reporting full-year results.


By Neil Thakrar; neilthakrar@alliancenews.com

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
26 Apr 2022 18:03

TRADING UPDATES: Billington faces headwinds; Immotion plans spin-off

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
23 Mar 2022 15:35

Futura signs up Korean partner for erection gel product

(Sharecast News) - Pharmaceutical and drug delivery technology developer Futura Medical has entered into a licensing agreement with Menarini Korea, it announced on Wednesday, for the exclusive rights to commercialise the company's topical gel-based erectile dysfunction treatment MED3000 in South Korea.

Read more
23 Mar 2022 11:50

Futura Medical shares rise on licensing deal with Menarini Korea

(Alliance News) - Futura Medical PLC shares jumped on Wednesday after the company said it has entered a licensing agreement with A Menarini Korea Ltd or the exclusive rights to commercialise its MED3000 treatment in South Korea.

Read more
20 Dec 2021 21:59

TRADING UPDATES: Silver Bullet faces cyber attack; Zoltav to delist

TRADING UPDATES: Silver Bullet faces cyber attack; Zoltav to delist

Read more
20 Dec 2021 10:46

Futura Medical makes good progress with topical erection gel treatment

(Sharecast News) - Futura Medical updated the market on regulatory and commercial progress for 'MED3000', its topical gel formulation for the treatment of erectile dysfunction, on Monday.

Read more
29 Oct 2021 15:57

EXECUTIVE CHANGES: TP chair resigns amid pressure from Science Group

EXECUTIVE CHANGES: TP chair resigns amid pressure from Science Group

Read more
8 Oct 2021 13:51

EXECUTIVE CHANGES: WH Ireland hires new CFO; Grubhub founder exits JET

EXECUTIVE CHANGES: WH Ireland hires new CFO; Grubhub founder exits JET

Read more
29 Sep 2021 13:22

EARNINGS UPDATES: Pittards swings to profit; Immupharma loss widens

EARNINGS UPDATES: Pittards swings to profit; Immupharma loss widens

Read more
27 Sep 2021 16:54

Futura Medical inks licensing deal with Labtec Pharma

(Sharecast News) - Transdermal drug delivery technology company Futura Medical has entered into a licensing agreement with Labatec Pharma, a Switzerland-based specialty pharma company focussed on commercialisation in the Europe and Middle East and North Africa (MENA) regions, it announced on Monday.

Read more
27 Sep 2021 12:01

IN BRIEF: Futura Medical teams with Labatec to commercialise MED3000

IN BRIEF: Futura Medical teams with Labatec to commercialise MED3000

Read more
22 Sep 2021 17:53

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
15 Sep 2021 20:23

IN BRIEF: Futura progressing US regulatory submission for MED3000

IN BRIEF: Futura progressing US regulatory submission for MED3000

Read more
1 Sep 2021 20:56

TRADING UPDATES: Sanderson Selfridges deal; Cazoo ups Forward Partners

TRADING UPDATES: Sanderson Selfridges deal; Cazoo ups Forward Partners

Read more
31 Aug 2021 15:08

Futura enters erection gel licensing deal with M8

(Sharecast News) - Futura Medical has entered into a licensing agreement with M8 Pharmaceuticals, a specialty biopharmaceutical company focused on commercialisation in Latin America, for the rights to exclusively develop and commercialise its topical, gel-based erectile dysfunction (ED) treatment MED3000 in Brazil and Mexico, it announced on Tuesday.

Read more
19 Jul 2021 19:13

TRADING UPDATES: Sareum raises GBP1 million; Marlowe buys Core Stream

TRADING UPDATES: Sareum raises GBP1 million; Marlowe buys Core Stream

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.